Medication Information Sample Clauses

Medication Information. You may disregard this section if none of the children you are registering for VBS are currently taking any medication. Medications: My child/children is/are taking medication at present. My child/children will bring all such medications necessary and such medications will be well-labeled. Please clearly indicate names of medications and concise directions for seeing that the child/children takes such medications, including dosage and frequency of dosage, and which child is taking which medication are as follows: As Parent or Guardian, I agree to all of the above/previously stated considerations and conditions. Signature: Date: AUTHORIZATION, CONSENT AND RELEASE FOR USE OF VISUAL LIKENESSES AND ORIGINAL WORKS OF MINORS This form allows you, the parent or guardian, to identify if images of your child/children and their original works may be used for purposes of print, online, social media communication and promotion. I am the parent or legal guardian of (full name of minor(s) participating in VBS (“My Child/Children”). I grant the following rights to St. Xxxxxxx’s Catholic Community and the Archdiocese of Saint Xxxx and Minneapolis:
AutoNDA by SimpleDocs
Medication Information. Number of medications needed during service contract: Name of Medication (only enter one medication here): _ Amount Given: (For additional medications, please fill out addition medication information on the next sheet starting with #2) Time to Administer: Give meds times for days. Reason for Medication: Known side effects: Instructions for administration: Has pet been on this medication before: □ Yes □ No Any known problems with administering: □ Yes □ No Please Describe: Policies and Procedures The client agrees to the following:
Medication Information. Allergies: Allergic to What Reaction Current Medications: Medication Strength Medication Strength Herbal/Over-the-Counter/Nutritional Products: Product Taken How Often Product Taken How Often Diseases/Conditions Disease/Condition Year Diagnosed Disease/Condition Year Diagnosed *Please provide your prescription insurance card before we fill your prescription PHOTO CONSENT I freely give my consent to have my picture taken and be used by Xxxxxx’x Pharmacy and Home Medical for my patient file. Printed Name: _ Signature: Date: Witness: Defiance • 0000 Xxxx Xxxxxx Xxxxxx, Xxxxxxxx, XX 00000 • (000) 000-0000 • Fax (000) 000-0000 Continental • P.O. Box 388, Continental, OH 45831 • (000) 000-0000 • Fax (000) 000-0000 Lab Work Levels of hormones can be helpful in evaluating your replacement needs. We suggest that you have your physician get base line levels of your hormones before starting human bio-identical hormone replacement. Levels can be checked by either blood or saliva sample. If you prefer to have saliva testing, please contact the pharmacy for a saliva kit. Blood levels will have to be drawn at your physician’s office. The following labs are what we suggest you have drawn or collected: Males: Testosterone Free DHEA-sulfate SHBG Estradiol LH PSA Cortisol—4 point (If under a lot of stress) Thyroid (T4 total and free, T3 total and free, TSH, Vit D 25, Vit D 25 OH, Ferritin) (if tired, constipated, cold blooded, depressed, or experiencing weight gain)
Medication Information. Allergies: Allergic to What Reaction Current Medications: Medication Strength Medication Strength Herbal/Over-the-Counter/Nutritional Products: Product Taken How Often Product Taken How Often Diseases/Conditions Disease/Condition Year Diagnosed Disease/Condition Year Diagnosed *Please provide your prescription insurance card before we fill your prescription ADRENAL QUESTIONAIRE If you answer yes to 3 or more of these questions, you may have some degree of adrenal burnout: Are you tired for “no reason”? Do you have trouble getting up in the morning? Do you need coffee or colas to keep you going? Do you feel run down and stressed? Do you crave salty or sweet snacks? Are you struggling to keep up with life’s daily demands? Can you not bounce back from stress or illness? Are you not having fun anymore? Is your sex drive decreased? Do you have difficulty falling/staying asleep or do you have trouble shutting your mind off at night? Do you have vivid nightmares or dreams? Do you have low blood pressure (lower than 110 on the top and lower than 70 on the bottom)? Do you feel as if you could take a nap an hour or so after lunch? Do you eat at least one processed or sweetened food at each meal or frequently skip meals? Are your pupils normally dilated even during the day? Do you seem to get sick or suffer from allergies more frequently than you used to? Do you feel pressured or rushed often during the day? Do you experience lightheadedness, mood swings or headaches if you go more than 4-6 hours between meals? MEMORY QUESTIONAIRE Over the last year, I have experienced: Becoming forgetful Lapses in memory Becoming less attentive Less interest in normal activities Feeling less sharp Difficulty remembering people’s names Difficulty making decisions Problems finding the right words to communicate Difficulty solving routine problems Difficulty learning new things Problems writing, reading, or organizing thoughts Difficulty following instructions Amino Acid Deficiency Symptoms Instructions: Mark the box or boxes that identify your corresponding symptoms. L-glutamine ฀ Cravings for sugar, starch, or alcohol ฀ Reduced mental stability L-tyrosine, L-phenylalanine ฀ Depression ฀ Lack of energy ฀ Lack of drive ฀ Lack of focus, concentration GABA ฀ Stiff and tense muscles ฀ Stressed ฀ Feeling “burned out” ฀ Unable to relax DL-phenylalanine, D-phenylalanine ฀ Very sensitive to emotional or physical pain ฀ Cry easily ฀ Crave comfort, reward, or numbing treats ฀ “Love” certain foo...
Medication Information. Allergies: Allergic to What Reaction Current Medications: Medication Strength Medication Strength Herbal/Over-the-Counter/Nutritional Products: Product Taken How Often Product Taken How Often Diseases/Conditions Disease/Condition Year Diagnosed Disease/Condition Year Diagnosed *Please provide your prescription insurance card before we fill your prescription
Medication Information. While on a GDS overnight activity, and recognizing that students may at times be out of a chaperone’s supervision (i.e during a homestay), students are allowed to self-medicate. For all prescription medications that a student takes, a Medication Action Plan is required. Please note that a Medication Action Plan must be signed by both the student’s health provider and parent/guardian. Students medicating with a prescribed drug may carry only the dosage sufficient to last for the duration of the trip. Medication should be carried in a standard pharmaceutical container and must be properly labeled with student name, medication name, dose and directions for administration. (Should you, as parents/guardians, prefer that your child not self-medicate, please contact the trip chaperone and school nurse to discuss whether we can accommodate your request.) Because school personnel may not provide students with any over-the-counter medication, students are permitted to possess and use common headache, antihistamine, and anti-diarrhea medications when they are listed below. As with prescribed drugs, students may carry only the dosage needed for the trip and may do so only in a properly labeled container. Under no circumstances are students permitted to give or sell any prescription or nonprescription, over-the-counter or other drug to another student. Violation of this rule may subject a student to disciplinary action. If your child takes medicine on an emergency or regular basis, please indicate such on this form. We must be notified of any and all prescription and over-the-counter medication brought on the trip. This includes inhalers and epinephrine auto-injectors. Students carrying emergency medication such as inhalers and epinephrine auto-injectors should inform the chaperones where these are stored in case they are needed in an emergency. will be bringing the following Prescription Medications: **must also complete a Medication Action Plan for each medication listed below Name of Medication Dosage and Time Reason Note Over the Counter Medications (does not require a Medication Action Plan): Name of Medication Dosage and Time Reason Note SIGNATURE OF PARENT/GUARDIAN Date
Medication Information. Prescription medication can be administered by staff with written permission from parents/guardians. Children are not to carry medication in their bags. Please note that any medication not in the original container and clearly labeled with the child’s name and dosage WILL NOT BE ADMINISTERED. All children requiring medications must fill out a Medical Information sheet upon enrolment to our Centre. Buzi Kidz OOSH welcomes children with additional needs. However, before enrolment we do require detailed information about your child’s individual needs. If your child has high support needs, additional support may be required via the Commonwealth Government’s Inclusion Support Subsidy (ISS). Contact us as soon as possible on 0421785545 Communication and Parent Involvement At our Centre we encourage positive and open communication between all parties involved. Communication between Parents and Staff is crucial to the everyday running of the Centre. The Centre will communicate with Parents and Carers through newsletters, notices, emails, and general verbal communication. Parents are always welcome at our Centre to watch or play with their children. We understand how busy families are but we do encourage your input and participation where possible. Please feel free to comment or give feedback within all areas of the service.
AutoNDA by SimpleDocs

Related to Medication Information

  • Application Information Employees’ spouses, registered same-sex domestic partners and eligible dependents who choose to participate in the Student Fee Authorization Program must follow the University’s application and enrollment procedures.

  • Union Information On a quarterly basis, the Employer shall provide the Union with the name, address, telephone number, hire date, classification, employment status, and pay rate of bargaining unit members.

  • Transaction Information The Adviser shall furnish to the Trust such information concerning portfolio transactions as may be necessary to enable the Trust or its designated agent to perform such compliance testing on the Funds and the Adviser’s services as the Trust may, in its sole discretion, determine to be appropriate. The provision of such information by the Adviser to the Trust or its designated agent in no way relieves the Adviser of its own responsibilities under this Agreement.

  • Program Information The Heritage Greece Program is generally described in the literature provided to the Student and available online at: xxxx://xxx.xxx.xxx. It is understood and agreed that the information contained therein is descriptive only and may be changed in the discretion of ACG which reserves the right to make Program changes at any time and for any reason, with or without notice. ACG and/or the Sponsor shall not be liable to the Student because of any such change. ACG reserves all rights, in its sole discre tion, to cancel the Program or any aspect thereof prior to or after departure, and in the case of cancellation after departure, to require the Student to return to the United States, if ACG determines or believes it is in the best interests of the Student.

  • Verizon Information Upon request by CBB, Verizon shall make available to CBB the following information to the extent that Verizon provides such information to its own business offices: a directory list of relevant NXX codes, directory and Customer Guide close dates, and Yellow Pages headings. Verizon shall also make available to CBB, on Verizon’s Wholesale website (or, at Verizon’s option, in writing) Verizon’s directory listings standards and specifications.

  • Treatment of Confidential Information (a) The Parties shall not, and shall cause all other Persons providing Services or having access to information of the other Party that is known to such Party as confidential or proprietary (the “Confidential Information”) not to, disclose to any other Person or use, except for purposes of this Agreement, any Confidential Information of the other Party; provided, however, that the Confidential Information may be used by such Party to the extent that such Confidential Information has been (i) in the public domain through no fault of such Party or any member of such Group or any of their respective Representatives or (ii) later lawfully acquired from other sources by such Party (or any member of such Party’s Group), which sources are not themselves bound by a confidentiality obligation; provided, further, that each Party may disclose Confidential Information of the other Party, to the extent not prohibited by applicable Law: (A) to its Representatives on a need-to-know basis in connection with the performance of such Party’s obligations under this Agreement; (B) in any report, statement, testimony or other submission required to be made to any Governmental Authority having jurisdiction over the disclosing Party; or (C) in order to comply with applicable Law, or in response to any summons, subpoena or other legal process or formal or informal investigative demand issued to the disclosing Party in the course of any litigation, investigation or administrative proceeding. In the event that a Party becomes legally compelled (based on advice of counsel) by deposition, interrogatory, request for documents subpoena, civil investigative demand or similar judicial or administrative process to disclose any Confidential Information of the other Party, such disclosing Party shall provide the other Party with prompt prior written notice of such requirement, and, to the extent reasonably practicable, cooperate with the other Party (at such other Party’s expense) to obtain a protective order or similar remedy to cause such Confidential Information not to be disclosed, including interposing all available objections thereto, such as objections based on settlement privilege. In the event that such protective order or other similar remedy is not obtained, the disclosing Party shall furnish only that portion of the Confidential Information that has been legally compelled, and shall exercise its commercially reasonable efforts (at such other Party’s expense) to obtain assurance that confidential treatment will be accorded such Confidential Information.

  • Confidential System Information HHSC prohibits the unauthorized disclosure of Other Confidential Information. Grantee and all Grantee Agents will not disclose or use any Other Confidential Information in any manner except as is necessary for the Project or the proper discharge of obligations and securing of rights under the Contract. Grantee will have a system in effect to protect Other Confidential Information. Any disclosure or transfer of Other Confidential Information by Xxxxxxx, including information requested to do so by HHSC, will be in accordance with the Contract. If Grantee receives a request for Other Confidential Information, Xxxxxxx will immediately notify HHSC of the request, and will make reasonable efforts to protect the Other Confidential Information from disclosure until further instructed by the HHSC. Grantee will notify HHSC promptly of any unauthorized possession, use, knowledge, or attempt thereof, of any Other Confidential Information by any person or entity that may become known to Grantee. Grantee will furnish to HHSC all known details of the unauthorized possession, use, or knowledge, or attempt thereof, and use reasonable efforts to assist HHSC in investigating or preventing the reoccurrence of any unauthorized possession, use, or knowledge, or attempt thereof, of Other Confidential Information. HHSC will have the right to recover from Grantee all damages and liabilities caused by or arising from Grantee or Grantee Agents’ failure to protect HHSC’s Confidential Information as required by this section. IN COORDINATION WITH THE INDEMNITY PROVISIONS CONTAINED IN THE UTC, Xxxxxxx WILL INDEMNIFY AND HOLD HARMLESS HHSC FROM ALL DAMAGES, COSTS, LIABILITIES, AND EXPENSES (INCLUDING WITHOUT LIMITATION REASONABLE ATTORNEYS’ FEES AND COSTS) CAUSED BY OR ARISING FROM Grantee OR Grantee AGENTS FAILURE TO PROTECT OTHER CONFIDENTIAL INFORMATION. Grantee WILL FULFILL THIS PROVISION WITH COUNSEL APPROVED BY HHSC.

  • E4 Confidential Information E4.1 Except to the extent set out in this clause or where disclosure is expressly permitted elsewhere in this Contract, each Party shall:

  • HANDLING OF CONFIDENTIAL INFORMATION The Company agrees to undertake the following in relation to IHiS’ Confidential Information: to maintain the same in confidence and to use it only for the Purpose and for no other purpose; not to make any commercial use thereof; not to use the same for the benefit of itself or of any third party other than pursuant to a further agreement with IHiS; not to use the same for the purpose of guiding or conducting a search of any information, materials or sources, whether or not available to the public, for any purpose whatsoever, including without limitation, for the purpose of demonstrating that any information falls within one of the exceptions in Clause 1.1(b); not to copy, reproduce, reverse engineer or reduce to writing any part thereof except as may be reasonably necessary for the Purpose and that any copies, reproductions or reductions to writing so made shall be the property of IHiS; not to disclose the Confidential Information whether to its employees or to third parties except in confidence to such of its Representatives who have been informed of the confidential nature thereof and who need to know the same for the Purpose and that: such Representatives are contractually obliged (whether by their contracts of employment or service, or otherwise) not to disclose the same or to use the same otherwise than for the Purpose; and the Company shall enforce such obligations at its expense, and to such extent as may be required by IHiS, in the event of a breach thereof that relates to IHiS' Confidential Information; to ensure the compliance to this NDA (including sub-clauses (a) to (f) above) on the part of its Representatives to whom Confidential Information is disclosed; and to apply to the Confidential Information no lesser security measures and degree of care than those which the Company applies to its own confidential or proprietary information of similar nature, but in no event less than reasonable care, and which the Company warrants as being adequate protection of such information from unauthorised disclosure, copying or use. The Company, as the principal party, shall be responsible and held liable for any breach of this NDA by any of its Representatives. If the Company is uncertain as to whether any information is Confidential Information, the Company shall treat the information as if it was Confidential Information, unless otherwise agreed by IHiS in writing. The Company shall immediately notify IHiS of any unauthorised disclosure or use of the Confidential Information of which the Company becomes aware and will take all steps which IHiS may require in relation to such unauthorised disclosure or use, or to prevent further unauthorised disclosure or use. Notwithstanding the foregoing, the Company shall be entitled to make any disclosure of the Confidential Information as required by law, but shall give IHiS not less than TWO (2) business days' notice of such disclosure and shall consult with IHiS prior to such disclosure with a view to avoiding such disclosure, if legally possible.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

Time is Money Join Law Insider Premium to draft better contracts faster.